Nanobiotix SA (NANO) Stock Price & News

Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia

About Nanobiotix SA

CEOLaurent Levy

Employees98

Founded2003

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websitenanobiotix.com

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.98M	2.98M	2.78M	2.78M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	4.29M	4.29M	6.36M	6.36M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.53M	4.53M	5.38M	5.38M
Operating expense	8.83M	8.83M	11.74M	11.74M
Total operating expenses	8.83M	8.83M	11.74M	11.74M
Operating income	-5.85M	-5.85M	-8.96M	-8.96M
Other non operating income	-8.50K	-8.50K	-1.00K	-1.00K
EBT including unusual items	-9.29M	-9.29M	-17.14M	-17.14M
EBT excluding unusual items	-8.57M	-8.57M	-16.56M	-16.56M
Income tax expense	-1.50K	-1.50K	8.00K	8.00K
Effective tax rate	0.02%	0.02%	-0.05%	-0.05%
Other operating expenses	-	-	-	-
Net income	-9.29M	-9.29M	-17.14M	-17.14M
Net profit margin	-311.97%	-311.97%	-617.69%	-617.69%
Earnings per share	-	-	-	-
Interest and investment income	193.50K	193.50K	338.50K	338.50K
Interest expense	-3.08M	-3.08M	-7.28M	-7.28M
Net interest expenses	-2.88M	-2.88M	-6.94M	-6.94M
Depreciation and amortization charges	-	-	-	-
EBITDA	-5.79M	-5.79M	-8.84M	-8.84M
Gain or loss from assets sale	76.50K	76.50K	-	-

Ask anything